Literature DB >> 30606719

Chemoprevention of Lung Carcinogenesis by Dietary Nicotinamide and Inhaled Budesonide.

Arthur R Galbraith1, Donna E Seabloom2,3, Beverly R Wuertz2,3, Jennifer D Antonides1, Vernon E Steele4, Lee W Wattenberg1, Frank G Ondrey5,2,3.   

Abstract

Nicotinamide, the amide form of vitamin B3, and budesonide, a synthetic glucocorticoid used in the treatment of asthma, were evaluated to determine their individual and combinational chemopreventive efficacy on benzo(a)pyrene-induced lung tumors in female A/J mice. Nicotinamide fed at a dietary concentration of 0.75% significantly inhibited tumor multiplicity. Nicotinamide by aerosol inhalation at doses up to 15 mg/kg/day did not result in a statistically significant reduction in tumor multiplicity. Finally, dietary nicotinamide was administered with aerosol budesonide and tumor multiplicity reduced by 90% at 1 week and 49% at 8 weeks post last carcinogen dose. We conclude nicotinamide is an effective and safe agent for lung cancer dietary prevention at both early- and late-stage carcinogenesis and that efficacy is increased with aerosol budesonide. Combination chemoprevention with these agents is a well-tolerated and effective strategy which could be clinically advanced to human studies. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30606719     DOI: 10.1158/1940-6207.CAPR-17-0402

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  6 in total

Review 1.  NAD+ metabolism and retinal degeneration (Review).

Authors:  Andreea Silvia Pîrvu; Ana Marina Andrei; Elena Camelia Stănciulescu; Ileana Monica Baniță; Cătălina Gabriela Pisoschi; Sanda Jurja; Radu Ciuluvica
Journal:  Exp Ther Med       Date:  2021-04-23       Impact factor: 2.447

2.  Intranasal Iloprost Prevents Tumors in a Murine Lung Carcinogenesis Model.

Authors:  Meredith A Tennis; Alex J Smith; Lori D Dwyer-Nield; Robert L Keith
Journal:  Cancer Prev Res (Phila)       Date:  2021-09-23

3.  Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation.

Authors:  Scarlett Acklin; Ratan Sadhukhan; Wuying Du; Mousumi Patra; Ravi Cholia; Fen Xia
Journal:  Neurooncol Adv       Date:  2022-06-27

4.  Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features.

Authors:  Hitoshi Dejima; Xin Hu; Runzhe Chen; Jiexin Zhang; Junya Fujimoto; Edwin R Parra; Cara Haymaker; Shawna M Hubert; Dzifa Duose; Luisa M Solis; Dan Su; Junya Fukuoka; Kazuhiro Tabata; Hoa H N Pham; Nicholas Mcgranahan; Baili Zhang; Jie Ye; Lisha Ying; Latasha Little; Curtis Gumbs; Chi-Wan Chow; Marcos Roberto Estecio; Myrna C B Godoy; Mara B Antonoff; Boris Sepesi; Harvey I Pass; Carmen Behrens; Jianhua Zhang; Ara A Vaporciyan; John V Heymach; Paul Scheet; J Jack Lee; Jia Wu; P Andrew Futreal; Alexandre Reuben; Humam Kadara; Ignacio I Wistuba; Jianjun Zhang
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

Review 5.  The Role of Nicotinamide in Cancer Chemoprevention and Therapy.

Authors:  Ilias P Nikas; Stavroula A Paschou; Han Suk Ryu
Journal:  Biomolecules       Date:  2020-03-20

6.  Nicotinamide inhibits melanoma in vitro and in vivo.

Authors:  Francesca Scatozza; Federica Moschella; Daniela D'Arcangelo; Stefania Rossi; Claudio Tabolacci; Claudia Giampietri; Enrico Proietti; Francesco Facchiano; Antonio Facchiano
Journal:  J Exp Clin Cancer Res       Date:  2020-10-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.